Stephen Oliver (scientist)

Last updated

Steve Oliver

FMedSci
Born
Stephen George Oliver

(1949-11-03) 3 November 1949 (age 74) [1]
Alma mater University of Bristol
Known for
Awards
Scientific career
Institutions
Thesis The role of RNA in the maintenance of mitochondrial DNA in the yeast, Saccharomyces cerevisiae.  (1975)
Website www.bioc.cam.ac.uk/research/oliver OOjs UI icon edit-ltr-progressive.svg

Stephen George Oliver FMedSci (born 3 November 1949) is an Emeritus Professor in the Department of Biochemistry at the University of Cambridge, [6] [7] and a Fellow of Wolfson College, Cambridge. [3] [8]

Contents

Education

Oliver was educated at the University of Bristol gaining a Bachelor of Science degree in Microbiology in 1971 followed by a PhD from the National Institute for Medical Research (NIMR) in 1974. [9]

Research

Oliver's areas of research include functional genomics, systems biology [10] [11] [12] and drug discovery [13] [14] [15] [16] [17] [18] using the model organism Saccharomyces cerevisiae [19] which he has worked on since the 1970s. [20] In 1992, whilst working at UMIST, Oliver led the team which provided first complete sequence analysis of an entire chromosome from any organism. [21] More recently he has also been involved in the creation of a Robot Scientist [2] [22] and has been awarded research funding as principal investigator or co-investigator with a total value of over £26 million by the Biotechnology and Biological Sciences Research Council ((BBSRC). [23]

Related Research Articles

<span class="mw-page-title-main">Model organism</span> Organisms used to study biology across species

A model organism is a non-human species that is extensively studied to understand particular biological phenomena, with the expectation that discoveries made in the model organism will provide insight into the workings of other organisms. Model organisms are widely used to research human disease when human experimentation would be unfeasible or unethical. This strategy is made possible by the common descent of all living organisms, and the conservation of metabolic and developmental pathways and genetic material over the course of evolution.

<span class="mw-page-title-main">Yeast artificial chromosome</span> Genetically engineered chromosome derived from the DNA of yeast

Yeast artificial chromosomes (YACs) are genetically engineered chromosomes derived from the DNA of the yeast, Saccharomyces cerevisiae, which is then ligated into a bacterial plasmid. By inserting large fragments of DNA, from 100–1000 kb, the inserted sequences can be cloned and physically mapped using a process called chromosome walking. This is the process that was initially used for the Human Genome Project, however due to stability issues, YACs were abandoned for the use of bacterial artificial chromosome

<span class="mw-page-title-main">Interactome</span> Complete set of molecular interactions in a biological cell

In molecular biology, an interactome is the whole set of molecular interactions in a particular cell. The term specifically refers to physical interactions among molecules but can also describe sets of indirect interactions among genes.

<span class="mw-page-title-main">Hans Westerhoff</span> Dutch biologist and biochemist (born 1953)

Hans Victor Westerhoff is a Dutch biologist and biochemist who is professor of synthetic systems biology at the University of Amsterdam and AstraZeneca professor of systems biology at the University of Manchester. Currently he is a Chair of AstraZeneca and a director of the Manchester Centre for Integrative Systems Biology.

Gerald Mayer Rubin is an American biologist, notable for pioneering the use of transposable P elements in genetics, and for leading the public project to sequence the Drosophila melanogaster genome. Related to his genomics work, Rubin's lab is notable for development of genetic and genomics tools and studies of signal transduction and gene regulation. Rubin also serves as a vice president of the Howard Hughes Medical Institute and executive director of the Janelia Research Campus.

<span class="mw-page-title-main">POLR1C</span> Protein-coding gene in the species Homo sapiens

DNA-directed RNA polymerases I and III subunit RPAC1 is a protein that in humans is encoded by the POLR1C gene.

<span class="mw-page-title-main">Chris Ponting</span> British computational biologist

Christopher Paul Ponting is a British computational biologist, specializing in the evolution and function of genes and genomes. He is currently Chair of Medical Bioinformatics at the University of Edinburgh and group leader in the MRC Human Genetics Unit. He is also an Associate Faculty member of the Wellcome Trust Sanger Institute, a Fellow of the Academy of Medical Sciences, member of the European Molecular Biology Organisation and Fellow of the Royal Society of Edinburgh. His research focuses on long noncoding RNA function and evolution, on single cell biology and on disease genomics. Outside of science, Chris is an amateur novelist and wrote an unpublished, science fiction novel about engineered viruses.

<span class="mw-page-title-main">Douglas Kell</span> British biochemist

Chief Sci

Robot Scientist is a laboratory robot created and developed by a group of scientists including Ross King, Kenneth Whelan, Ffion Jones, Philip Reiser, Christopher Bryant, Stephen Muggleton, Douglas Kell, Emma Byrne and Steve Oliver.

Bernhard Ørn Palsson is the Galletti Professor of Bioengineering and an adjunct professor of Medicine at the University of California, San Diego.

Gerard Ian Evan FRS, FMedSci is a British biologist and, since May 2022, Professor of Cancer Biology at King's College London and a principal group leader in the Francis Crick Institute. Prior to this he was Sir William Dunn Professor and Head of Biochemistry at the University of Cambridge (2009-2022).

<span class="mw-page-title-main">Ross D. King</span> Professor at the University of Manchester

Ross Donald King is a Professor of Machine Intelligence at Chalmers University of Technology.

Norman William Paton is a Professor in the Department of Computer Science at the University of Manchester in the UK where he co-leads the Information Management Group (IMG) with Carole Goble.

<span class="mw-page-title-main">Steve Pettifer</span>

Stephen Robert Pettifer is a Professor in the Department of Computer Science at the University of Manchester in England.

<span class="mw-page-title-main">Julian Parkhill</span> Geneticist, working with pathogens

Julian Parkhill is Professor of Bacterial Evolution in the Department of Veterinary Medicine at the University of Cambridge. He previously served as head of pathogen genomics at the Wellcome Sanger Institute.

<span class="mw-page-title-main">David Broomhead</span> British mathematician

David S. Broomhead was a British mathematician specialising in dynamical systems and was professor of applied mathematics at the School of Mathematics, University of Manchester.

<span class="mw-page-title-main">Peter Colman</span>

Peter Malcolm Colman is the head of the structural biology division at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia.

<span class="mw-page-title-main">Robin Allshire</span>

Robin Campbell Allshire is Professor of Chromosome Biology at University of Edinburgh and a Wellcome Trust Principal Research Fellow. His research group at the Wellcome Trust Centre for Cell Biology focuses on the epigenetic mechanisms governing the assembly of specialised domains of chromatin and their transmission through cell division.

Individualized medicine tailors treatment to a single patient. The term refers to an individual, truly personalized medicine that strives to treat each patient on the basis of his own individual biology.

<span class="mw-page-title-main">Peter Karl Sorger</span> American cancer biologist (born 1961)

Peter Karl Sorger is a systems and cancer biologist and Otto Krayer Professor of Systems Pharmacology in the Department of Systems Biology at Harvard Medical School. Sorger is the founding head of the Harvard Program in Therapeutic Science (HiTS), director of its Laboratory of Systems Pharmacology (LSP), and co-director of the Harvard MIT Center for Regulatory Science. He was previously a Professor of Biology and Biological Engineering at the Massachusetts Institute of Technology where he co-founded its program on Computational and Systems Biology (CSBi). Sorger is known for his work in the field of systems biology and for having helped launch the field of computational and systems pharmacology. His research focuses on the molecular origins of cancer and approaches to accelerate the development of new medicines. Sorger teaches Principles and Practice of Drug Development at Massachusetts Institute of Technology and Harvard University.

References

  1. 1 2 3 Anon (2014). "Oliver, Prof. Stephen George" . Who's Who (online edition via Oxford University Press  ed.). A & C Black. doi:10.1093/ww/9780199540884.013.U247362.(Subscription or UK public library membership required.)
  2. 1 2 King, R. D.; Whelan, K. E.; Jones, F. M.; Reiser, P. G. K.; Bryant, C. H.; Muggleton, S. H.; Kell, D. B.; Oliver, S. G. (2004). "Functional genomic hypothesis generation and experimentation by a robot scientist". Nature. 427 (6971): 247–252. Bibcode:2004Natur.427..247K. doi:10.1038/nature02236. PMID   14724639. S2CID   4428725.
  3. 1 2 "Professor Steve Oliver | Wolfson College Cambridge". Archived from the original on 8 August 2014.
  4. ↑ Cornell, M.; Paton, N. W.; Oliver, S. G. (2004). "A critical and Integrated View of the Yeast Interactome". Comparative and Functional Genomics. 5 (5): 382–402. doi:10.1002/cfg.412. PMC   2447467 . PMID   18629175.
  5. ↑ Oliver, S. (1977). "On the mutability of the yeast mitochondrial genome". Journal of Theoretical Biology. 67 (2): 195–201. Bibcode:1977JThBi..67..195O. doi:10.1016/0022-5193(77)90193-X. PMID   330960.
  6. ↑ Stephen Oliver publications from Europe PubMed Central
  7. ↑ "Steve Oliver — Cambridge Systems Biology Centre". 5 November 2012. Archived from the original on 14 January 2013.
  8. ↑ Stephen Oliver's publications indexed by the Scopus bibliographic database. (subscription required)
  9. ↑ Oliver, Stephen (1975). The role of RNA in the maintenance of mitochondrial DNA in the yeast, Saccharomyces cerevisiae (PhD thesis). Council for National Academic Awards. ProQuest   301313077.
  10. ↑ Von Mering, C.; Krause, R.; Snel, B.; Cornell, M.; Oliver, S.; Fields, S.; Bork, P. (2002). "Comparative assessment of large-scale data sets of protein-protein interactions". Nature. 417 (6887): 399–403. Bibcode:2002Natur.417..399V. doi:10.1038/nature750. PMID   12000970. S2CID   4419762.
  11. ↑ Goffeau, A.; Barrell, B. G.; Bussey, H.; Davis, R. W.; Dujon, B.; Feldmann, H.; Galibert, F.; Hoheisel, J. D.; Jacq, C.; Johnston, M.; Louis, E. J.; Mewes, H. W.; Murakami, Y.; Philippsen, P.; Tettelin, H.; Oliver, S. G. (1996). "Life with 6000 Genes". Science. 274 (5287): 546, 563–7. Bibcode:1996Sci...274..546G. doi:10.1126/science.274.5287.546. PMID   8849441. S2CID   16763139.
  12. ↑ Oliver, S. G.; Teusink, L. M.; Broadhurst, B.; Zhang, D.; Hayes, N.; Walsh, A.; Berden, M. C.; Brindle, J. A.; Kell, K. M.; Rowland, D. B.; Westerhoff, J. J.; Van Dam, H. V.; Oliver, K. (2001). "A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations". Nature Biotechnology. 19 (1): 45–50. doi:10.1038/83496. PMID   11135551. S2CID   15491882.
  13. ↑ Kell, D. B.; Dobson, P. D.; Bilsland, E.; Oliver, S. G. (2012). "The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: What we (need to) know and how we can do so". Drug Discovery Today. 18 (5–6): 218–39. doi:10.1016/j.drudis.2012.11.008. PMID   23207804.
  14. ↑ Lanthaler, K.; Bilsland, E.; Dobson, P. D.; Moss, H. J.; Pir, P. N.; Kell, D. B.; Oliver, S. G. (2011). "Genome-wide assessment of the carriers involved in the cellular uptake of drugs: A model system in yeast". BMC Biology. 9: 70. doi: 10.1186/1741-7007-9-70 . PMC   3280192 . PMID   22023736.
  15. ↑ Kell, D. B.; Dobson, P. D.; Oliver, S. G. (2011). "Pharmaceutical drug transport: The issues and the implications that it is essentially carrier-mediated only". Drug Discovery Today. 16 (15–16): 704–714. doi:10.1016/j.drudis.2011.05.010. PMID   21624498.
  16. ↑ Dobson, P. D.; Smallbone, K.; Jameson, D.; Simeonidis, E.; Lanthaler, K.; Pir, P.; Lu, C.; Swainston, N.; Dunn, W. B.; Fisher, P.; Hull, D.; Brown, M.; Oshota, O.; Stanford, N. J.; Kell, D. B.; King, R. D.; Oliver, S. G.; Stevens, R. D.; Mendes, P. (2010). "Further developments towards a genome-scale metabolic model of yeast". BMC Systems Biology. 4: 145. doi: 10.1186/1752-0509-4-145 . PMC   2988745 . PMID   21029416.
  17. ↑ Dobson, P. D.; Lanthaler, K.; Oliver, S. G.; Kell, D. B. (2009). "Implications of the dominant role of transporters in drug uptake by cells". Current Topics in Medicinal Chemistry. 9 (2): 163–181. doi:10.2174/156802609787521616. PMID   19200003.
  18. ↑ Herrgård, M. J.; Swainston, N.; Dobson, P.; Dunn, W. B.; Arga, K. Y. I.; Arvas, M.; Blüthgen, N.; Borger, S.; Costenoble, R.; Heinemann, M.; Hucka, M.; Le Novère, N.; Li, P.; Liebermeister, W.; Mo, M. L.; Oliveira, A. P.; Petranovic, D.; Pettifer, S.; Simeonidis, E.; Smallbone, K.; Spasić, I.; Weichart, D.; Brent, R.; Broomhead, D. S.; Westerhoff, H. V.; Kirdar, B. L.; Penttilä, M.; Klipp, E.; Palsson, B. Ø.; Sauer, U.; Oliver, S.G.; Mendes, P.; Nielsen, J.; Kell, D.B. (2008). "A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology". Nature Biotechnology. 26 (10): 1155–1160. doi:10.1038/nbt1492. PMC   4018421 . PMID   18846089.
  19. ↑ Von Mering, C.; Krause, R.; Snel, B.; Cornell, M.; Oliver, S.; Fields, S.; Bork, P. (2002). "Comparative assessment of large-scale data sets of protein-protein interactions". Nature. 417 (6887): 399–403. Bibcode:2002Natur.417..399V. doi:10.1038/nature750. PMID   12000970. S2CID   4419762.
  20. ↑ Oliver, S. G.; Williamson, D. H. (1976). "The molecular events involved in the induction of petite yeast mutants by fluorinated pyrimidines". MGG Molecular & General Genetics. 146 (3): 253–259. doi:10.1007/BF00701248. PMID   794690. S2CID   23632777.
  21. ↑ Oliver, S. G.; Van Der Aart, Q. J. M.; Agostoni-Carbone, M. L.; Aigle, M.; Alberghina, L.; Alexandraki, D.; Antoine, G.; Anwar, R.; Ballesta, J. P. G.; Benit, P.; Berben, G.; Bergantino, E.; Biteau, N.; Bolle, P. A.; Bolotin-Fukuhara, M.; Brown, A.; Brown, A. J. P.; Buhler, J. M.; Carcano, C.; Carignani, G.; Cederberg, H.; Chanet, R.; Contreras, R.; Crouzet, M.; Daignan-Fornier, B.; Defoor, E.; Delgado, M.; Demolder, J.; Doira, C.; et al. (1992). "The complete DNA sequence of yeast chromosome III". Nature. 357 (6373): 38–46. Bibcode:1992Natur.357...38O. doi:10.1038/357038a0. PMID   1574125. S2CID   4271784.
  22. ↑ King, P.; Rowland, J.; Aubrey, W.; Liakata, M.; Markham, M.; Soldatova, L. N.; Whelan, K. E.; Clare, A.; Young, M.; Sparkes, A.; Oliver, S. G.; Pir, P. (2009). "The Robot Scientist Adam". Computer. 42 (7): 46–54. doi:10.1109/MC.2009.270. S2CID   13920692.
  23. ↑ "UK Government Grants awarded to Stephen Oliver" . Retrieved 4 July 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.